Secondaries announced 8.18.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: MediciNova, Inc. Symbol: MNOV Price: Last trade $3.54 Trade Date: 8/19 Shares: TBD Underwriter(s) Ladenburg Thalmann Co Manager(s) Mizuho Securities, SMBC[…]